Ageing sensitized by iPLA2β deficiency induces liver fibrosis and intestinal atrophy involving suppression of homeostatic genes and alteration of intestinal lipids and bile acids / Li Jiao, Hongying Gan-Schreier, Xingya Zhu, Wang Wei, Sabine Tuma-Kellner, Gerhard Liebisch, Wolfgang Stremmel, Walee Chamulitrat
Ageing is a major risk factor for various forms of liver and gastrointestinal (GI) disease and genetic background may contribute to the pathogenesis of these diseases. Group VIA phospholipase A2 or iPLA2β is a homeostatic PLA2 by playing a role in phospholipid metabolism and remodeling. Global iPLA2β−/− mice exhibit aged-dependent phenotypes with body weight loss and abnormalities in the bone and brain. We have previously reported the abnormalities in these mutant mice showing susceptibility for chemical-induced liver injury and colitis. We hypothesize that iPLA2β deficiency may sensitize with ageing for an induction of GI injury. Male wild-type and iPLA2β−/− mice at 4 and 20-22months of age were studied. Aged, but not young, iPLA2β−/−mice showed increased hepatic fibrosis and biliary ductular expansion as well as severe intestinal atrophy associated with increased apoptosis, pro-inflammation, disrupted tight junction, and reduced number of mucin-containing globlet cells. This damage was associated with decreased expression of intestinal endoplasmic stress XBP1 and its regulator HNF1α, FATP4, ACSL5, bile-acid transport genes as well as nuclear receptors LXRα and FXR. By LC/MS-MS profiling, iPLA2β deficiency in aged mice caused an increase of intestinal arachidonate-containing phospholipids concomitant with a decrease in ceramides. By the suppression of intestinal FXR/FGF-15 signaling, hepatic bile-acid synthesis gene expression was increased leading to an elevation of secondary and hydrophobic bile acids in liver, bile, and intestine. In conclusions, ageing sensitized by iPLA2β deficiency caused a decline of key intestinal homeostatic genes resulting in the development of GI disease in a gut-to-liver manner..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
06 September 2017 2017 |
---|---|
Erschienen: |
06 September 2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:1862 |
---|---|
Enthalten in: |
Biochimica et biophysica acta - 1862(2017), 12, Seite 1520-1533 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jiao, Li [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Available online 06 September 2017 Gesehen am 28.08.2018 |
---|
Umfang: |
14 |
---|
doi: |
10.1016/j.bbalip.2017.09.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1580437559 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1580437559 | ||
003 | DE-627 | ||
005 | 20230427065659.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180828s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bbalip.2017.09.001 |2 doi | |
035 | |a (DE-627)1580437559 | ||
035 | |a (DE-576)510437559 | ||
035 | |a (DE-599)BSZ510437559 | ||
035 | |a (OCoLC)1341017624 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Jiao, Li |e verfasserin |0 (DE-588)1110067860 |0 (DE-627)864777914 |0 (DE-576)475712900 |4 aut | |
245 | 1 | 0 | |a Ageing sensitized by iPLA2β deficiency induces liver fibrosis and intestinal atrophy involving suppression of homeostatic genes and alteration of intestinal lipids and bile acids |c Li Jiao, Hongying Gan-Schreier, Xingya Zhu, Wang Wei, Sabine Tuma-Kellner, Gerhard Liebisch, Wolfgang Stremmel, Walee Chamulitrat |
264 | 1 | |c 06 September 2017 | |
300 | |a 14 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Available online 06 September 2017 | ||
500 | |a Gesehen am 28.08.2018 | ||
520 | |a Ageing is a major risk factor for various forms of liver and gastrointestinal (GI) disease and genetic background may contribute to the pathogenesis of these diseases. Group VIA phospholipase A2 or iPLA2β is a homeostatic PLA2 by playing a role in phospholipid metabolism and remodeling. Global iPLA2β−/− mice exhibit aged-dependent phenotypes with body weight loss and abnormalities in the bone and brain. We have previously reported the abnormalities in these mutant mice showing susceptibility for chemical-induced liver injury and colitis. We hypothesize that iPLA2β deficiency may sensitize with ageing for an induction of GI injury. Male wild-type and iPLA2β−/− mice at 4 and 20-22months of age were studied. Aged, but not young, iPLA2β−/−mice showed increased hepatic fibrosis and biliary ductular expansion as well as severe intestinal atrophy associated with increased apoptosis, pro-inflammation, disrupted tight junction, and reduced number of mucin-containing globlet cells. This damage was associated with decreased expression of intestinal endoplasmic stress XBP1 and its regulator HNF1α, FATP4, ACSL5, bile-acid transport genes as well as nuclear receptors LXRα and FXR. By LC/MS-MS profiling, iPLA2β deficiency in aged mice caused an increase of intestinal arachidonate-containing phospholipids concomitant with a decrease in ceramides. By the suppression of intestinal FXR/FGF-15 signaling, hepatic bile-acid synthesis gene expression was increased leading to an elevation of secondary and hydrophobic bile acids in liver, bile, and intestine. In conclusions, ageing sensitized by iPLA2β deficiency caused a decline of key intestinal homeostatic genes resulting in the development of GI disease in a gut-to-liver manner. | ||
650 | 4 | |a Ageing | |
650 | 4 | |a FXR | |
650 | 4 | |a Intestinal homeostasis | |
650 | 4 | |a Lipidomics | |
650 | 4 | |a Pla2G6 | |
650 | 4 | |a XBP1 | |
700 | 1 | |a Gan-Schreier, Hongying |d 1967- |e verfasserin |0 (DE-588)130102040 |0 (DE-627)490859860 |0 (DE-576)297997955 |4 aut | |
700 | 1 | |a Zhu, Xingya |d 1990- |e verfasserin |0 (DE-588)1165586487 |0 (DE-627)1029648123 |0 (DE-576)51043696X |4 aut | |
700 | 1 | |a Wei, Wang |d 1985- |e verfasserin |0 (DE-588)1094885118 |0 (DE-627)855358300 |0 (DE-576)462842827 |4 aut | |
700 | 1 | |a Tuma-Kellner, Sabine |e verfasserin |0 (DE-588)111098653X |0 (DE-627)865272743 |0 (DE-576)475865979 |4 aut | |
700 | 1 | |a Stremmel, Wolfgang |d 1952- |e verfasserin |0 (DE-588)142773638 |0 (DE-627)640118747 |0 (DE-576)33331560X |4 aut | |
700 | 1 | |a Chamulitrat, Walee |d 1959- |e verfasserin |0 (DE-588)1037336828 |0 (DE-627)755493915 |0 (DE-576)39134479X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochimica et biophysica acta |d Amsterdam [u.a.] : Elsevier, 1947 |g 1862(2017), 12, Seite 1520-1533 |h Online-Ressource |w (DE-627)253779626 |w (DE-600)1460387-1 |w (DE-576)072793821 |x 1878-2434 |7 nnns |
773 | 1 | 8 | |g volume:1862 |g year:2017 |g number:12 |g pages:1520-1533 |g extent:14 |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1388198117301865 |x Verlag |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbalip.2017.09.001 |x Verlag |x Resolving-System |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |d 1862 |j 2017 |e 12 |h 1520-1533 |g 14 |
951 | |a AR | ||
952 | |d 1862 |j 2017 |e 12 |h 1520-1533 |g 14 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3024032185 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 28-08-18 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2017 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_8 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_14 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)154571505X |a Jiao, Li | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1503623920 |a Gan-Schreier, Hongying | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1580437184 |a Zhu, Xingya | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s p |0 (DE-627)1539132595 |a Wei, Wang | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416740686 |a Klinikum der Universität Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |a pos_4 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s p |0 (DE-627)1553698800 |a Tuma-Kellner, Sabine | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1416822720 |a Extern | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |a pos_5 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s p |0 (DE-627)1436010535 |a Stremmel, Wolfgang | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |a pos_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s p |0 (DE-627)1461346029 |a Chamulitrat, Walee | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s s |a pos_8 |